Gracell Biotechnologies’ $209 Million Initial Public Offering

Davis Polk and Zhong Lun advised the underwriters in the offering. Wilson Sonsini Goodrich & Rosati advised Gracell Biotechnologies Inc. on the deal. Gracell Biotechnologies Inc….

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here